I think the PAR shorters are very happy. They are massively in the money with most of the short positions being opened between $2.50 and $3.50. FDA IND application approval is expected, so I would expect the spike in share price will be temporary. Only a partnership/JV will potentially catch the shorters off-guard.
research reports and media, page-2010
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
0.005(2.00%) |
Mkt cap ! $91.06M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 26.0¢ | 25.0¢ | $29.18K | 114.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 31381 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 1594 | 1 |
View Market Depth
| Last trade - 15.00pm 17/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |